MSHJ Research Associates Report issue

For profit Phase 3
Founded: Halifax NS Canada (1993)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00519714
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

trigonellamide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertriglyceridemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1